Enlivex Therapeutics Ltd (ENLV)
0.9800 -0.0400 (-3.92%) 13:01 ET [NASDAQ]
0.9760 x 5 0.9801 x 1
Realtime by (Cboe BZX)
0.9760 x 5 0.9801 x 1
Realtime 1.0100 -0.0100 (-0.98%) 07:13 ET
for Mon, Mar 31st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 813 | 49,945 | 11,202 | 6,844 | 5,448 |
| Marketable Securities | 26,507 | 299 | 72,928 | 30,034 | 8,060 |
| Receivables | N/A | N/A | N/A | N/A | 2,000 |
| Other current assets | 5,108 | 0 | 0 | 0 | 0 |
| TOTAL | $33,764 | $52,330 | $86,442 | $38,121 | $16,421 |
| Non-Current Assets | |||||
| PPE Net | 1,539 | 9,875 | 2,530 | 1,481 | 648 |
| Other Non-Current Assets | 1,528 | 5,437 | 6,174 | 756 | 491 |
| TOTAL | $3,067 | $15,312 | $8,704 | $2,237 | $1,139 |
| Total Assets | $36,831 | $67,642 | $95,146 | $40,358 | $17,560 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 827 | 1,948 | 878 | 463 | 316 |
| Accrued Expenses | 4,001 | 4,659 | 3,840 | 2,738 | 2,264 |
| Other current liabilities | N/A | N/A | N/A | 1,171 | 3,400 |
| TOTAL | $6,061 | $6,607 | $4,718 | $4,372 | $5,980 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 686 | 4,194 | 5,389 | 499 | 298 |
| TOTAL | $686 | $4,194 | $5,389 | $499 | $298 |
| Total Liabilities | $6,747 | $10,801 | $10,107 | $4,871 | $6,278 |
| Shareholders' Equity | |||||
| Common Shares | 2,137 | 2,117 | 2,107 | 1,646 | 1,151 |
| Retained earnings | -112,093 | -83,025 | -51,965 | -37,497 | -25,673 |
| Other shareholders' equity | 1,101 | 1,101 | 1,101 | 977 | -1,300 |
| TOTAL | $30,084 | $56,841 | $85,039 | $35,487 | $11,282 |
| Total Liabilities And Equity | $36,831 | $67,642 | $95,146 | $40,358 | $17,560 |